immune plasma (high-titer)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for immune plasma (high-titer), covering 2019-06-14 to 2019-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A [Phase 3]